[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin. 2018, 68(6): 394-424.
[2] Arnold M, Sierra M S, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut. 2017, 66(4): 683-691.
[3] Batista P J. The RNA Modification N(6)-methyladenosine and Its Implications in Human Disease[J]. Genomics Proteomics Bioinformatics. 2017, 15(3): 154-163.
[4] Hsu P J, Zhu Y, Ma H, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis[J]. Cell Res. 2017, 27(9): 1115-1127.
[5] Bokar J A, Shambaugh M E, Polayes D, et al. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase[J]. RNA. 1997, 3(11): 1233-1247.
[6] Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation[J]. Nat Chem Biol. 2014, 10(2): 93-95.
[7] Ping X L, Sun B F, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase[J]. Cell Res. 2014, 24(2): 177-189.
[8] Zheng G, Dahl J A, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility[J]. Mol Cell. 2013, 49(1): 18-29.
[9] Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO[J]. Nat Chem Biol. 2011, 7(12): 885-887.
[10] Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability[J]. Nature. 2014, 505(7481): 117-120.
[11] Liu N, Dai Q, Zheng G, et al. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions[J]. Nature. 2015, 518(7540): 560-564.
[12] Xu C, Wang X, Liu K, et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain[J]. Nat Chem Biol. 2014, 10(11): 927-929.
[13] Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA[J]. Cell Res. 2017, 27(3): 315-328.
[14] Du H, Zhao Y, He J, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex[J]. Nat Commun. 2016, 7: 12626.
[15] Xiao W, Adhikari S, Dahal U, et al. Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing[J]. Mol Cell. 2016, 61(4): 507-519.
[16] Kretschmer J, Rao H, Hackert P, et al. The m(6)A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5'-3' exoribonuclease XRN1[J]. RNA. 2018, 24(10): 1339-1350.
[17] Zhao B S, Wang X, Beadell A V, et al. m(6)A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition[J]. Nature. 2017, 542(7642): 475-478.
[18] Geula S, Moshitch-Moshkovitz S, Dominissini D, et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation[J]. Science. 2015, 347(6225): 1002-1006.
[19] Fanale D, Iovanna J L, Calvo E L, et al. Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?[J]. Expert Opin Ther Targets. 2014, 18(8): 841-850.
[20] Tanabe A, Konno J, Tanikawa K, et al. Transcriptional machinery of TNF-alpha-inducible YTH domain containing 2 (YTHDC2) gene[J]. Gene. 2014, 535(1): 24-32.
[21] Jain D, Puno M R, Meydan C, et al. ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2[J]. Elife. 2018, 7.
[22] Soh Y, Mikedis M M, Kojima M, et al. Meioc maintains an extended meiotic prophase I in mice[J]. PLoS Genet. 2017, 13(4): e1006704.
[23] Wojtas M N, Pandey R R, Mendel M, et al. Regulation of m(6)A Transcripts by the 3'-->5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline[J]. Mol Cell. 2017, 68(2): 374-387.
[24] Bailey A S, Batista P J, Gold R S, et al. The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline[J]. Elife. 2017, 6.
[25] Liu X, Shimada T, Otowa T, et al. Genome-wide Association Study of Autism Spectrum Disorder in the East Asian Populations[J]. Autism Res. 2016, 9(3): 340-349.
[26] Fanale D, Iovanna J L, Calvo E L, et al. Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?[J]. Expert Opin Ther Targets. 2014, 18(8): 841-850.
[27] Tanabe A, Tanikawa K, Tsunetomi M, et al. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1alpha mRNA is translated[J]. Cancer Lett. 2016, 376(1): 34-42.
[28] Sturgill T W, Ray L B. Muscle proteins related to microtubule associated protein-2 are substrates for an insulin-stimulatable kinase[J]. Biochem Biophys Res Commun. 1986, 134(2): 565-571.
[29] Barr R K, Bogoyevitch M A. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs)[J]. Int J Biochem Cell Biol. 2001, 33(11): 1047-1063.
[30] Zou X, Blank M. Targeting p38 MAP kinase signaling in cancer through post-translational modifications[J]. Cancer Lett. 2017, 384: 19-26.
[31] Zhou G, Bao Z Q, Dixon J E. Components of a new human protein kinase signal transduction pathway[J]. J Biol Chem. 1995, 270(21): 12665-12669.
[32] Schett G, Zwerina J, Firestein G. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis[J]. Ann Rheum Dis. 2008, 67(7): 909-916.
[33] Adcock I M, Caramori G, Chung K F. New targets for drug development in asthma[J]. Lancet. 2008, 372(9643): 1073-1087.
[34] Wang Y, Xia C, Lv Y, et al. Crosstalk Influence between P38MAPK and Autophagy on Mitochondria-Mediated Apoptosis Induced by Anti-Fas Antibody/Actinomycin D in Human Hepatoma Bel-7402 Cells[J]. Molecules. 2017, 22(10).